KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2025)

Historic Inventory Average for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to $9.2 million.

  • Adaptive Biotechnologies' Inventory Average fell 2714.85% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year decrease of 2714.85%. This contributed to the annual value of $11.4 million for FY2024, which is 2080.55% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Inventory Average stood at $9.2 million, which was down 2714.85% from $8.5 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Inventory Average high stood at $20.1 million for Q1 2022, and its period low was $8.5 million during Q2 2025.
  • In the last 5 years, Adaptive Biotechnologies' Inventory Average had a median value of $17.0 million in 2023 and averaged $15.5 million.
  • In the last 5 years, Adaptive Biotechnologies' Inventory Average soared by 7319.95% in 2021 and then tumbled by 3990.51% in 2024.
  • Adaptive Biotechnologies' Inventory Average (Quarter) stood at $18.7 million in 2021, then decreased by 15.19% to $15.9 million in 2022, then increased by 6.73% to $17.0 million in 2023, then plummeted by 39.91% to $10.2 million in 2024, then decreased by 10.1% to $9.2 million in 2025.
  • Its last three reported values are $9.2 million in Q3 2025, $8.5 million for Q2 2025, and $8.6 million during Q1 2025.